PALVELLA THERAPEUTICS, INC. Common Stock Shares Outstanding

Quick Answer

PALVELLA THERAPEUTICS, INC. reported Common Stock Shares Outstanding of 12.38 million shares for the year ending 2025.

  • PALVELLA THERAPEUTICS, INC. showed an increase of +12.4% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from PALVELLA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: 5.00 million shares | Q2 2014: 6.10 million shares | Q3 2014: 6.25 million shares | Q1 2015: 29.43 million shares | Q2 2015: 29.43 million shares | Q3 2015: 39.76 million shares | Q1 2016: 39.83 million shares | Q2 2016: 43.06 million shares | Q3 2016: 43.06 million shares | Q1 2017: 43.06 million shares | Q2 2017: 43.84 million shares | Q3 2017: 44.70 million shares | Q1 2018: 53.97 million shares | Q2 2018: 54.01 million shares | Q3 2018: 54.15 million shares | Q1 2019: 49.15 million shares | Q2 2019: 49.26 million shares | Q3 2019: 49.39 million shares | Q2 2022: 74.26 million shares | Q1 2025: 11.02 million shares | Q2 2025: 11.06 million shares | Q3 2025: 11.09 million shares.
  • Over the full 16 years of available data (2013 to 2025), PALVELLA THERAPEUTICS, INC.'s Common Stock Shares Outstanding has grown by 147.6%.
  • Historical annual values: Fiscal year 2025: 12.38 million shares | Fiscal year 2024: 11.01 million shares | Fiscal year 2023: 1.77 million shares | Fiscal year 2022: 74.52 million shares | Fiscal year 2021: 72.22 million shares | Fiscal year 2020: 56.00 million shares | Fiscal year 2019: 55.21 million shares | Fiscal year 2018: 54.15 million shares | Fiscal year 2017: 45.02 million shares | Fiscal year 2016: 43.06 million shares | Fiscal year 2015: 39.83 million shares | Fiscal year 2014: 29.28 million shares | Fiscal year 2014: 13.86 million shares | Fiscal year 2014: 6.10 million shares | Fiscal year 2013: 11.83 million shares | Fiscal year 2013: 5.00 million shares.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: